Orbimed Capital LLC, Director, 10% Owner at Prelude Therapeutics Inc (PRLD), bought 1,739,130 shares at $5.75 ($10.0M) on 2023-05-22, disclosed to the SEC on 2023-05-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.75 | 869,565 | $5.0M | 50.0% |
| 2 | $5.75 | 869,565 | $5.0M | 50.0% |
| Total | $5.75 avg | 1,739,130 | $10.0M | 100% |
| Filing → |
| ARQT | SELL | 2022-04-08 | $25.4M | — | Filing → |
| RPTX | SELL | 2021-08-30 | $993K | — | Filing → |
| RPTX | SELL | 2021-08-25 | $1.2M | — | Filing → |